TipRanks
Go Ultimate55% OFF

Parenteral Drugs (India) Limited (PDPL) Stock Price & Analysis

PDPL Stock Chart & Stats

$2.90$0.00(0.00%)
At close: 1:30 AM GMT+5:30
No data to display
Day’s Range
N/A
52-Week Range
N/A
Previous Close
N/A
Volume
1,063
Average Volume (3M)
N/A
Market Cap
INR 101.08M
Enterprise Value
INR 1173.07T
Total Cash (Recent Filing)
INR 1,000
Total Debt (Recent Filing)
INR 1.07B
Price to Earnings (P/E)
―
Beta
N/A
Next Earnings
N/A
EPS Estimate
N/A
Dividend Yield
N/A

PDPL FAQ

What is Parenteral Drugs (India) Limited’s market cap?
Parenteral Drugs (India) Limited’s market cap is ₹101.08M.
When is Parenteral Drugs (India) Limited’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Parenteral Drugs (India) Limited’s earnings last quarter?
Parenteral Drugs (India) Limited released its earnings results on May 30, 2022. The company reported $7.99 earnings per share for the quarter.
Is Parenteral Drugs (India) Limited overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Parenteral Drugs (India) Limited pay dividends?
Parenteral Drugs (India) Limited pays a Notavailable dividend of $1.125 which represents an annual dividend yield of ―. See more information on Parenteral Drugs (India) Limited dividends here
What is Parenteral Drugs (India) Limited’s EPS estimate?
Parenteral Drugs (India) Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Parenteral Drugs (India) Limited have?
Parenteral Drugs (India) Limited has 29,816,300 shares outstanding.
What happened to Parenteral Drugs (India) Limited’s price movement after its last earnings report?
Parenteral Drugs (India) Limited reported an EPS of $7.99 in its last earnings report. Following the earnings report the stock price went same ―.
Which hedge fund is a major shareholder of Parenteral Drugs (India) Limited?
Currently, no hedge funds are holding shares in IN:PDPL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology